1-6 of 6
Sabina Adhikary
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Two-year update of ZUMA-2 Cohort 3: Brexucabtagene autoleucel (Brexu-cel) in patients (pts) with relapsed/refractory mantle cell lymphoma (R/R MCL) who had not received prior Bruton tyrosine kinase inhibitor (BTKi) therapy

Free
Tom Van Meerten, Marie José Kersten, Gloria Iacoboni, Georg Hess, Pim Mutsaers, Alejandro Martin Garcia-Sancho, Andre Goy, Eva Gine, Brian Hill, Wen-Kai Weng, Martin Dreyling, Patrick Reagan, Krish Patel, Ahmed Galal, Charles Herbaux, Robin Sanderson, Dan Zheng, Sabina Adhikary, Wangshu Zhang, Rita Damico Khalid, Ioana Kloos, Michael Wang
Journal: Blood
Blood (2025) 146 (Supplement 1): 1799.
https://doi.org/10.1182/blood-2025-1799
Published: 2025
Journal Articles

Endogenous regulation of inflammatory response as a determinant of durable remission without stem cell transplant following brexucabtagene autoleucel (Brexu-cel) therapy in ALL

Free
Sabina Adhikary, Colleen Schweitzer, Daqin Mao, Rita Damico Khalid, Rhine Shen, Jae Park
Journal: Blood
Blood (2025) 146 (Supplement 1): 1588.
https://doi.org/10.1182/blood-2025-1588
Published: 2025
Journal Articles

Impact of Disease Burden, CAR-T Expansion, and Mononuclear Cell Recovery on Overall Response and Duration of Response in Zuma-3 Pivotal Study

Free
Sabina Adhikary, Colleen Schweitzer, Fang Sun, Daqin Mao, Sharon Mu, Srikanth Mannem, Rubina Siddiqi, Tsveta Hadjivassileva, Rita Damico Khalid, Rhine Shen
Journal: Blood
Blood (2024) 144 (Supplement 1): 4193.
https://doi.org/10.1182/blood-2024-208999
Published: 2024
Journal Articles

Updated Outcomes from the Historical Control Study SCHOLAR-3 Contextualizing ZUMA-3 Results of Brexucabtagene Autoleucel (KTE-X19) in Adult Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL)

Free
Bijal D. Shah, Armin Ghobadi, Olalekan O. Oluwole, Aaron C. Logan, Nicolas Boissel, Ryan D. Cassaday, Thibaut Leguay, Michael R. Bishop, Max S. Topp, Dimitrios Tzachanis, Kristen M. O'Dwyer, Martha L. Arellano, Yi Lin, Maria R. Baer, Gary J. Schiller, Jae H Park, Marion Subklewe, Mehrdad Abedi, Monique C. Minnema, William G. Wierda, Daniel J. DeAngelo, Patrick Stiff, Deepa Jeyakumar, Jinghui Dong, Sabina Adhikary, Lang Zhou, Petra C. Schuberth, Imi Faghmous, Behzad Kharabi Masouleh, Roch Houot
Journal: Blood
Blood (2022) 140 (Supplement 1): 3158–3161.
https://doi.org/10.1182/blood-2022-158248
Published: 2022
Journal Articles

Regression of Epithelial Cancers Following T Cell Receptor Gene Therapy Targeting Human Papillomavirus-16 E7

Free
Scott Michael Norberg, DO, Nisha Nagarsheth, PhD, Stacey Doran, MD, Jennifer A Kanakry, MD, Sabina Adhikary, PhD, Colleen Schweitzer, PhD, Stephanie H Astrow, PhD, William Faquin, MD, Nikolaos Gkitsas, Steven Highfill, PhD, Christian S Hinrichs
Journal: Blood
Blood (2018) 132 (Supplement 1): 492.
https://doi.org/10.1182/blood-2018-99-117017
Published: 2018
Journal Articles

Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by inhibiting matrix metalloproteinase 9 expression

Free
Sabina Adhikary, Virginia P. Kocieda, Jui-Hung Yen, Ronald F. Tuma, Doina Ganea
Journal: Blood
Blood (2012) 120 (18): 3741–3749.
https://doi.org/10.1182/blood-2012-06-435362
Published: 2012
Includes: Supplemental data